Ovid Therapeutics
OVID
OVID
79 hedge funds and large institutions have $161M invested in Ovid Therapeutics in 2020 Q2 according to their latest regulatory filings, with 39 funds opening new positions, 18 increasing their positions, 17 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
10.89% more ownership
Funds ownership: 29.02% → 39.91% (+11%)
6% more repeat investments, than reductions
Existing positions increased: 18 | Existing positions reduced: 17
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Holders
79
Holding in Top 10
1
Calls
$768K
Puts
$434K
Top Buyers
| 1 | +$17.9M | |
| 2 | +$8.15M | |
| 3 | +$5.42M | |
| 4 |
Invesco
Atlanta,
Georgia
|
+$4.98M |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$3.21M |
Top Sellers
| 1 | -$2.24M | |
| 2 | -$2.09M | |
| 3 | -$1.74M | |
| 4 |
Renaissance Technologies
New York
|
-$1.69M |
| 5 |
IC
Ikarian Capital
Dallas,
Texas
|
-$1.13M |